@article{b708b72fa63e48a4a099e4b587c45e68,
title = "Evidence-based clinical practice guidelines for polycystic kidney disease 2014",
author = "Shigeo Horie and Toshio Mochizuki and Satoru Muto and Kazushige Hanaoka and Yoshimitsu Fukushima and Ichiei Narita and Kikuo Nutahara and Ken Tsuchiya and Kazuhiko Tsuruya and Koichi Kamura and Saori Nishio and Tatsuya Suwabe and Yoshifumi Ubara and Eiji Ishimura and Koichi Nakanishi and Keiichi Furukawa and Kenjiro Kimura and Seiichi Matsuo",
note = "Funding Information: Guidelines on four diseases (IgA nephropathy, nephrotic syndrome, RPGN, and polycystic kidney disease [PKD]) were created simultaneously by a research group on progressive kidney disorders (led by Seiichi Matsuo) funded by the Ministry of Health, Labour, and Welfare{\textquoteright}s research project for overcoming intractable diseases. All of these guidelines have the same chapter structure. PKD is a genetic disease, so Shinshu University professor Yoshimitsu Fukushima assisted by serving on the drafting committee as a representative of the Japan Society of Human Genetics. Keiichi Furukawa of the Division of Infectious Diseases in the Department of Internal Medicine at St. Luke{\textquoteright}s International Hospital provided assistance regarding cyst infections. We would like to take this opportunity to thank these two physicians for their generous help. ",
year = "2016",
month = aug,
day = "1",
doi = "10.1007/s10157-015-1219-7",
language = "English",
volume = "20",
pages = "493--509",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "4",
}